semaglutide cause heart problems GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% Kidney and Survival Benefits of

Making the wrong choice could derail your weight loss efforts

Semaglutide cut major cardiovascular events by 20% in patients who already had heart disease

Potential for type 2 diabetes and obesity treatment : Retatrutide is being studied for its effectiveness in treating both type 2 diabetes and obesity, offering hope for broader use in metabolic health

Maselli, MD, ABOM, a bariatric endoscopist and obesity medicine physician at True You Weight Loss in Georgia

What surprised researchers the most is that not only do these work to control type two diabetes, they also help people with obesity lose weight like nothing else really ever has